Ashley Milano  |  November 25, 2015

Category: Legal News

Top Class Actions’s website and social media posts use affiliate links. If you make a purchase using such links, we may receive a commission, but it will not result in any additional charges to you. Please review our Affiliate Link Disclosure for more information.

diabetic ketoacidosis diabetes medication invokana sglt2An Illinois resident filed an Invokana lawsuit against Janssen Pharmaceuticals and its parent company Johnson & Johnson for allegedly failing to adequately warn about the possibility of developing ketoacidosis.

Plaintiff Anthony A. claims in his Invokana lawsuitthat he developed ketoacidosis from taking the drug in December 2014 to treat his type-2 diabetes. Anthony further alleges that the pharmaceutical companies willfully concealed their knowledge of Invokana’s unreasonably dangerous risks in order to prevent any chance that U.S. Food and Drug Administration (FDA) approval of Invokana would be delayed.

Anthony claims had he relied on advertised claims that Invokana is a safe and effective treatment for type-2 diabetes, when, according to the Invokana lawsuit, the defendants knew, or should have known, the risks associated with the use of the diabetes medicine, including the risk of developing ketoacidosis.

About Invokana

Invokana was approved by the Food and Drug Administration on March 29, 2013 for treatment of type-2 diabetes. However, this May, the FDA warned in a safety communication that this drug may put patients at risk for a serious health condition known as ketoacidosis. When a drug that is already on the market poses a potential threat to patients, the FDA will review Adverse Event Reports and further investigate the drug.

In the case of Invokana, the FDA’s Center for Drug Evaluation and Research (CDER) is investigating a link between the use of Invokana and the development of a condition called diabetic ketoacidosis, a dangerous condition that can lead to hospitalization.

The FDA’s safety communication issued on May 15, instructed doctors to continue to monitor patients and to report all adverse events that may be linked to Invokana.

Invokana is a sodium-glucose contransporter-2 (SGLT2) inhibitor. Several other brand name SGLT2 inhibitor drugs were also identified by the FDA, including:

  • Invokamet
  • Farxiga
  • Xigduo XR
  • Jardiance
  • Glyxambi

These diabetes medications all share similar active ingredients that may lead to diabetic ketoacidosis (DKA), a serious condition in which the body produces high levels of blood acids called ketones.

What is Ketoacidosis?

Ketoacidosis occurs when the cells do not receive the glucose needed by your body for energy and the body begins to burn fat for energy, which produces ketones. When ketones build up in the bloodstream, it becomes more acidic and can poison your body.

Diabetic ketoacidosis can lead to serious health problems, including diabetic coma. Other complications include heart attack, blood clots, and kidney failure. In some situations, it can lead to death.

Invokana Lawsuits

Attorneys are investigating the possibility of filing Invokana diabetic ketoacidosis lawsuits against Johnson & Johnson, claiming that the drug maker knew, or should have known, of the high risk of diabetic ketoacidosis associated with its diabetes treatment but failed to provide adequate warning in an effort to protect their own profits.

If you or a loved one suffered serious Invokana side effects or side effects from another SGLT2 inhibitor drug, you may be owed compensation for medical expenses and other damages.

The Invokana Lawsuit is Case No. 3:15-cv-01195-DRH-DGW in the U.S. District Court for the Southern District of Illinois, East St. Louis Division.

In general, diabetes medication lawsuits are filed individually by each plaintiff and are not class actions.

Do YOU have a legal claim? Fill out the form on this page now for a free, immediate, and confidential case evaluation. The attorneys who work with Top Class Actions will contact you if you qualify to let you know if an individual lawsuit or class action lawsuit is best for you. Hurry — statutes of limitations may apply.

Learn More

We tell you about cash you can claim EVERY WEEK! Sign up for our free newsletter.


Get Help – It’s Free

Join a Free Diabetes Medication Class Action Lawsuit Investigation

If you or a loved one suffered ketoacidosis or kidney failure after taking Invokana, Invokamet, Farxiga, Xigduo XR, Jardiance or Glyxambi, you may have a legal claim. See if you qualify to pursue compensation and join a free diabetes medication class action lawsuit investigation by submitting your information for a free case evaluation.

An attorney will contact you if you qualify to discuss the details of your potential case.

Oops! We could not locate your form.

Please note: Top Class Actions is not a settlement administrator or law firm. Top Class Actions is a legal news source that reports on class action lawsuits, class action settlements, drug injury lawsuits and product liability lawsuits. Top Class Actions does not process claims and we cannot advise you on the status of any class action settlement claim. You must contact the settlement administrator or your attorney for any updates regarding your claim status, claim form or questions about when payments are expected to be mailed out.